GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Venus Remedies VENUSREM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,448.30

+0.04%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹7.70bn

FY2017FY2026

Net income

₹1.03bn

FY2017FY2026

Free cash flow

₹1.20bn

FY2017FY2026

Shareholders' equity

₹6.64bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹7.70bn₹6.48bn₹5.91bn₹5.56bn₹5.99bn₹5.48bn₹3.37bn₹3.17bn₹3.69bn₹3.96bn
Research and development₹181.7m₹180.8m₹158.4m₹228.9m₹230.3m₹157.6m₹142.5m₹146.5m₹306.4m₹85.7m
Operating income₹1.22bn₹410.3m₹447.4m₹380.5m₹366.1m₹239.0m₹111.8m−₹72.2m₹62.9m₹42.1m
Net income₹1.03bn₹453.2m₹284.9m₹265.7m₹407.2m₹617.7m−₹100.0m−₹285.7m−₹306.9m₹79.1m
Diluted earnings per share76.8933.9021.3119.8830.4746.13-8.10-23.17-24.866.89

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹8.54bn₹7.16bn₹6.27bn₹6.01bn₹5.80bn₹5.56bn₹6.38bn₹7.33bn₹7.51bn₹8.29bn
Cash and short-term investments₹1.04bn₹1.64bn₹838.0m₹720.8m₹453.1m₹288.8m₹19.4m₹20.3m₹7.4m₹10.4m
Total liabilities₹1.90bn₹1.55bn₹1.39bn₹1.41bn₹1.39bn₹1.56bn₹3.14bn₹4.00bn₹3.89bn₹3.78bn
Debt₹124.1m₹16.9m₹413.3m₹422.9m₹428.5m₹513.2m₹2.20bn₹2.98bn₹3.07bn₹3.12bn
Shareholders' equity₹6.64bn₹5.61bn₹4.88bn₹4.60bn₹4.40bn₹4.00bn₹3.23bn₹3.33bn₹3.62bn₹4.52bn
Shares outstanding13m13m13m13m13m13m12m12m12m11m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹1.57bn₹909.2m₹372.9m₹366.2m₹410.0m₹1.33bn₹770.1m₹453.3m₹514.4m₹997.2m
Capital spending−₹377.0m−₹96.3m−₹93.2m−₹78.2m−₹137.1m−₹77.3m−₹77.8m−₹99.2m−₹141.0m−₹503.5m
Free cash flow₹1.20bn₹812.9m₹279.7m₹288.0m₹272.9m₹1.25bn₹692.3m₹354.0m₹373.4m₹493.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.79bn₹2.59bn₹1.80bn₹1.93bn₹1.32bn₹1.95bn₹1.77bn₹1.67bn
Operating income₹274.2m₹566.7m₹309.7m₹265.0m₹39.2m₹242.9m₹248.9m₹90.9m
Net income₹229.7m₹474.9m₹255.8m₹201.3m₹96.0m₹210.0m₹196.0m₹35.1m
Diluted earnings per share17.1835.5319.1415.067.1815.7114.662.63
Cash from operations———₹811.0m—₹864.0m—₹255.0m
Capital spending———−₹128.0m—−₹180.0m—−₹114.0m
Free cash flow———₹683.0m—₹684.0m—₹141.0m
Total assets—₹8.54bn—₹7.68bn—₹7.16bn—₹6.60bn
Cash and short-term investments₹1.03bn₹1.04bn₹2.36bn₹2.36bn₹1.56bn₹1.64bn₹1.34bn₹1.34bn
Debt—₹13.6m—₹143.8m—₹16.9m—₹409.1m
Shareholders' equity₹6.64bn₹6.64bn₹5.94bn₹5.94bn₹5.61bn₹5.61bn₹4.94bn₹4.94bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.5%7.0%6.4%
Operating income47.3%38.5%42.6%
Net income57.0%10.7%50.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin11.5%9.6%8.2%5.8%
Net margin10.4%7.9%8.2%4.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings18.922.614.920.44.22.8-15.8-5.5-5.118.6
Price to sales2.51.60.71.00.30.30.50.50.40.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 Sept 2013.

FY2014FY2013FY2012FY2011FY2010FY2009
Paid in the year3.003.003.003.003.004.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.